| Scorecard |
|---|
|
3 / 5 Stars
|
|
Lipper
3
3
2
5
1
|
|
Zacks Investment Research
3
(Hold)
|
|
Standard & Poor's
3 / 5 Stars
|
|
TheStreet.com
D-
(Sell)
|
Fund Holdings
Asset Allocation
| % Long | % Short | % Net | |
|---|---|---|---|
| Cash | 7.39 | 4.33 | 3.07 |
| Stocks | 2.98 | 0.0 | 2.98 |
| Bonds | 0.0 | 0.0 | 0.0 |
| Other | 0.03 | 0.0 | 0.03 |
| Foreign Bonds | 0.0 | 0.0 | 0.0 |
| Foreign Stocks | 93.93 | 0.0 | 93.93 |
| Convertible | 0.0 | 0.0 | 0.0 |
| Preferred | 0.0 | 0.0 | 0.0 |
Updated 02.28.2013
Top 10 Holdings
Performance as of 04.30.2013
Portfolio as of 02.28.2013
| Ticker | YTD Return % | % Net Assets | |
|---|---|---|---|
| HSBC Holdings PLC | HBCYF | 4.07 | 1.91 |
| Roche Holding AG | RHHVF | 23.65 | 1.78 |
| Standard Chartered PLC | STAN | --- | 1.7 |
| Nestle SA | NSRGF | 9.65 | 1.65 |
| AIA Group Ltd. | AAIGF | --- | 1.33 |
| Novartis AG | NVSEF | 17.5 | 1.28 |
| BNP Paribas | BNP | --- | 1.08 |
| Barclays PLC | BCLYF | 3.02 | 1.0 |
| Fanuc Corp | 6954 | --- | 0.99 |
| Novo Nordisk A/S | NONOF | 5.13 | 0.98 |
